Biproxi
Burlingame, US · Founded 2018 · Delaware corporation · 2 known investors
Find your way into Biproxi
136 people in our graph share verified history with the Biproxi team — schools, employers, funds. One of them is your warm intro.
Biproxi operates a platform and network connecting commercial real estate (CRE) sponsors and investors to access and deploy capital and match deal opportunities. It targets CRE professionals, sponsors, and investors seeking to raise or place capital for real estate transactions.
Founders & leadership
Biproxi was founded in 2018 by Gordon Smith.
Investors · 2
Reported raises · per SEC filings
Form D private placements$150K disclosed across 1 round · 2018
▶$150KraisedApr 2018 · 3 investors · CommercialRule 506(b)
- Yan KhamishDirector, Promoter
- Gordon SmithExecutive Officer, Director, Promoter
- Guy CarringtonPromoter
- Amount sold
- $150K
- Minimum investment
- $50K
- Proceeds to insiders
- $200K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Biproxi for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Biproxi do?
- Biproxi operates a platform and network connecting commercial real estate (CRE) sponsors and investors to access and deploy capital and match deal opportunities. It targets CRE professionals, sponsors, and investors seeking to raise or place capital for real estate transactions.
- Who founded Biproxi?
- Biproxi was founded by Gordon Smith in 2018.
- Who are Biproxi's investors?
- Biproxi's investors include Rpm Ventures Iii Management, L.L.C., Greycroft.
- How much funding has Biproxi raised?
- Biproxi has disclosed $150K raised across 1 round.
- Where is Biproxi headquartered?
- Biproxi is headquartered in Burlingame, US.